Do I need scans if my SCC is considered high-risk? 

For the majority of individuals diagnosed with squamous cell carcinoma in the United Kingdom, the cancer is identified early and treated successfully without the need for complex imaging. However, when a lesion is classified as high-risk, a clinician may recommend specific scans to gain a deeper understanding of the tumour’s extent or to check if cells have travelled to nearby lymph nodes. These tests are not a routine requirement for every patient but are used strategically based on the biological features of the cancer and the physical findings during a clinical examination. By using modern imaging technology, the multidisciplinary team can ensure that the treatment plan is as precise as possible, targeting the cancer effectively while protecting the surrounding healthy structures. 

What We’ll Discuss in This Article 

• Clinical criteria that determine the need for imaging 

• The role of ultrasound in assessing regional lymph nodes 

• When CT or MRI scans are necessary for staging 

• Identifying bone invasion or nerve involvement through scans 

• How imaging results guide the surgical and oncological plan 

• The process of multidisciplinary team review for high-risk cases 

When imaging is clinically necessary 

Imaging is typically reserved for squamous cell carcinomas that show aggressive features or those where the boundaries of the cancer are difficult to define. While a physical examination and a biopsy provide vital information about the surface of the skin, they cannot always show how far a tumour has grown beneath the surface. The National Health Service explains that scans like CT or MRI may be needed if the doctor thinks the cancer has started to spread or if it is located in a high-risk area such as the ear or the lip. 

If a clinician identifies a tumour that is larger than four centimetres in diameter, or if the pathology report shows that the cancer has invaded deeply into the subcutaneous fat or muscle, staging scans are often requested. These tests help to confirm if the cancer remains localised or if it has reached the regional lymph nodes. By performing these scans, the healthcare team can provide a more accurate stage for the cancer, which is essential for deciding whether a simple excision is sufficient or if more extensive treatment is required. 

Types of scans used for high-risk SCC 

Different types of imaging are used to answer specific clinical questions about the cancer. Ultrasound is frequently used as a first line investigation to check the lymph nodes in the neck, armpit, or groin. It is a painless, non-invasive test that uses sound waves to create a detailed picture of the internal structure of the glands. A radiologist or a trained sonographer looks for signs of enlargement or a loss of the normal shape of the node, which could indicate the presence of cancer cells. 

In cases where a tumour is suspected of growing into the bone or following the path of a nerve, a CT or MRI scan is often preferred. A CT scan uses X-rays to create a cross-sectional view of the body and is particularly effective at identifying if a cancer has caused any damage to the underlying bone. An MRI scan provides superior detail of the soft tissues and is the gold standard for investigating perineural invasion, where the cancer cells grow along a nerve. These scans allow the surgical team to map the exact extent of the disease before an operation begins. 

The role of ultrasound in lymph node monitoring 

For patients with very high-risk squamous cell carcinoma, regular ultrasound monitoring of the regional lymph nodes may be recommended even if the nodes feel normal during a physical check. This is particularly common for tumours located on the scalp or the ears, where the lymphatic drainage often goes to the parotid glands in front of the ear or the deeper nodes in the neck. Ultrasound is much more sensitive than a physical examination and can detect microscopic changes in the glands before they can be felt by a doctor. 

NICE clinical guidelines recommend that for patients with high-risk squamous cell carcinoma, a lymph node ultrasound should be considered to check for early signs of metastasis, especially if the tumour has aggressive features under the microscope. If the ultrasound shows a suspicious node, the clinician may perform a fine needle aspiration on the same day to take a small sample of cells for testing. This proactive approach to surveillance ensures that any spread is caught and managed at the earliest possible opportunity. 

Clinical factors that trigger a request for scans 

The decision to order a scan is based on a combination of physical findings and the results of the initial biopsy. Several high-risk factors increase the likelihood that a doctor will request imaging: 

• Tumour size and depth: Any growth larger than four centimetres or one that is deeper than six millimetres. 

• Aggressive cell types: Pathology reports showing poorly differentiated or high-grade histological subtypes. 

• Nerve symptoms: New onset of numbness, tingling, or weakness in the muscles near the tumour. 

• Bony erosion: If the tumour feels fixed to the bone underneath or if there is visible evidence of bone damage. 

• Immunosuppression: Patients with weakened immune systems often require more frequent and detailed imaging. 

When these factors are present, the clinical risk of the cancer spreading is higher. Imaging provides the necessary safety net to ensure that the full burden of the disease is understood. For some patients, the absence of any suspicious findings on a scan is an excellent result that allows the medical team to proceed with a standard local treatment plan with greater confidence. 

How scan results influence the treatment plan 

The information gained from imaging is presented at a multidisciplinary team meeting, where specialists from dermatology, oncology, radiology, and surgery discuss the case. If a scan shows that the cancer is more extensive than initially thought, the treatment plan may be adjusted. For example, if a CT scan reveals that the cancer has reached the bone, the surgeon may need to plan a more complex reconstruction, or the oncology team may recommend a course of radiotherapy to ensure the area is fully treated. 

Scan results also determine if a regional lymph node dissection is necessary. If imaging and a subsequent biopsy confirm that the cancer has reached the nodes, a surgeon will perform an operation to remove the affected glands. Conversely, if the scans show that the nodes are clear, the patient can avoid more invasive surgery. This tailored approach ensures that every patient receives the most effective treatment for their specific stage of cancer while avoiding unnecessary procedures wherever possible. 

Conclusion 

Imaging scans are a vital tool for managing high-risk squamous cell carcinoma in the United Kingdom. While not every patient requires them, they are essential for staging aggressive tumours, checking regional lymph nodes, and identifying invasion into deeper structures. By combining clinical expertise with modern imaging, the NHS ensures that patients receive a precise and successful treatment plan. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.